{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:00:29Z","timestamp":1790229629471,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":5024,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","award":["DRTC P60-DK20595"],"award-info":[{"award-number":["DRTC P60-DK20595"]}],"id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RR-00055"],"award-info":[{"award-number":["RR-00055"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-041859"],"award-info":[{"award-number":["U54-041859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1RR024999"],"award-info":[{"award-number":["UL1RR024999"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.fertnstert.2012.03.059","type":"journal-article","created":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T12:01:24Z","timestamp":1335441684000},"page":"242-249.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Antim\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries"],"prefix":"10.1016","volume":"98","author":[{"given":"Robert L.","family":"Rosenfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Wroblewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasantha","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Littlejohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2012.03.059_bib1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocrin Rev"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib2","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: toward a rational approach","volume":"Vol. 4","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib3","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(85)92552-8","article-title":"Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone","volume":"2","author":"Adams","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib5","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib6","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib9","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2008-2248","article-title":"Characterization of functionally typical and atypical types of polycystic ovary syndrome","volume":"94","author":"Hirshfeld-Cytron","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib10","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib12","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1210\/jc.2008-2771","article-title":"Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population","volume":"94","author":"Mortensen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1479-828X.1994.tb01041.x","article-title":"The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women","volume":"34","author":"Farquhar","year":"1994","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib14","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/jc.2006-1085","article-title":"Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome","volume":"91","author":"Murphy","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib15","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jc.2010-0202","article-title":"The polycystic ovary post-Rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance","volume":"95","author":"Johnstone","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib17","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1210\/jc.2005-0907","article-title":"Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries","volume":"90","author":"Stubbs","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib19","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","article-title":"Anti-mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in\u00a0vitro","volume":"21","author":"Carlsson","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-mullerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/humrep\/deq019","article-title":"Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles","volume":"25","author":"Andersen","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib22","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.fertnstert.2009.10.022","article-title":"The cohort of antral follicles measuring 2\u20136 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-mullerian hormone and response to controlled ovarian stimulation","volume":"94","author":"Jayaprakasan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib23","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","article-title":"Anti-mullerian hormone (AMH): what do we still need to know?","volume":"24","author":"la Marca","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib25","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib26","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib27","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2010-0334","article-title":"Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-mullerian hormone concentrations aggregate with the markers of hyperandrogenism","volume":"95","author":"Dewailly","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib28","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1093\/humrep\/der300","article-title":"What's in a number? The polycystic ovary revisited","volume":"26","author":"Raine-Fenning","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib29","first-page":"3408","article-title":"Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin","volume":"81","author":"Rosenfield","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib30","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/humrep\/der223","article-title":"Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone","volume":"26","author":"Villarroel","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib31","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1210\/jc.2010-0930","article-title":"Serum levels of anti-mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients","volume":"95","author":"Hagen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib32","doi-asserted-by":"crossref","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","article-title":"A validated model of serum antimullerian hormone from conception to menopause","volume":"6","author":"Kelsey","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib33","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1210\/jc.2007-0729","article-title":"Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division","volume":"92","author":"Stubbs","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib34","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal anti-mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in\u00a0vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib36","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.03.059_bib37","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"}],"updated-by":[{"DOI":"10.1016\/j.fertnstert.2012.07.1106","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000}}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028212003974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028212003974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:18:51Z","timestamp":1775233131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028212003974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0015028212003974"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.03.059","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antim\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.03.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}